Skip to main content
Case Reports, Adverse Events, Transplant
Inadequate Transdermal Patch Absorption in a Patient with Scleroderma Associated with Graft-versus-Host Disease
Robert Mancini, PharmD, BCOP, FHOPA, Mallori Hooker, NP-C, AOCNP, BMTCN, William Kreisle, MD
Robert Mancini, PharmD, BCOP; Mallori Hooker, NP-C, AOCNP, BMTCN; William Kreisle, MD
Read More
Symptom Management Overview, Transplant
Clostridium difficile Infection Management in Adults Undergoing Stem-Cell Transplant
Tetyana Melnyk, PharmD
Tetyana Melnyk, PharmD
Read More
Original Research, Colorectal Cancer, Screening
Clinical and Budget Impact of Increasing Colorectal Cancer Screening by Blood- and Stool-Based Testing
Joshua A. Roth, PhD, MHA, Theo deVos, PhD, Scott D. Ramsey, MD, PhD
Joshua A. Roth, PhD, MHA; Theo deVos, PhD; Scott D. Ramsey, MD, PhD
Read More
FDA Updates
Recent Cancer Drugs Approved by the FDA
Read More
Meeting Highlights
ASH Highlights, CAR T-Cell Therapy, Lymphoma
Mosunetuzumab, a Dual-Targeted Antibody, Shows Complete Remissions in Relapsed/Refractory NHL After CAR T-Cell Therapy
Read More
Meeting Highlights
ASH Highlights, CAR T-Cell Therapy, Immunotherapy
Apamistamab-Based Lymphodepleting Regimen Before CAR T-Cell Therapy Prevents Cytokine Release Syndrome
Read More
Meeting Highlights
ASH Highlights, Leukemia
Zanubrutinib, Next-Generation BTK, Leads to Impressive Responses in Patients with CLL or SLL
Read More
Meeting Highlights
ASH Highlights, Leukemia
First-Line Acalabrutinib-Based Triplet Therapy Leads to Undetectable Minimal Residual Disease in CLL
Read More
Meeting Highlights
ASH Highlights, Leukemia
Investigational Oral Form of Azacitidine Improves Survival Maintenance Therapy in Patients with Acute Myeloid Leukemia
Read More
Meeting Highlights
ASH Highlights, Leukemia
All-Oral Time-Limited Combination Treatment for CLL or SLL Shows Early Impressive Efficacy
Read More
Page 143 of 200
Results 1421 - 1430 of 1993